The Association Between Medicare Low-income Subsidy and Anticancer Treatment Uptake in Advanced Lung Cancer.

High out-of-pocket costs may impact anticancer treatment uptake. Low-income subsidies (LIS) can reduce patient out-of-pocket cost for Medicare Part D-covered treatments. We examined whether LIS increased uptake and reduced time to initiate orally-administered anticancer drugs in patients with advanced non-small cell lung cancer (NSCLC).